Fundamentally a very sound pharma company which works very differently from generic pharma.
Future is very bright and is awaiting one big USFDA approval.
The stock could potentially breakout of of a C&H formation above 1000.
SL at 10% as i believe this stock deserves a chance to run.
Target open.
The only hitch is i am not expecting a great Q4 result from the company as becuase of the lockdown their current business has slowed down.
Future is very bright and is awaiting one big USFDA approval.
The stock could potentially breakout of of a C&H formation above 1000.
SL at 10% as i believe this stock deserves a chance to run.
Target open.
The only hitch is i am not expecting a great Q4 result from the company as becuase of the lockdown their current business has slowed down.